Gyanu Lamichhane

Gyanu Lamichhane

Johns Hopkins University

H-index: 38

North America-United States

About Gyanu Lamichhane

Gyanu Lamichhane, With an exceptional h-index of 38 and a recent h-index of 30 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of antibiotics, drug resistance, peptidoglycan, M. tuberculosis, non-tuberculous mycobacteria.

His recent articles reflect a diverse array of research interests and contributions to the field:

Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations

Oxazolidinone for treatment of infections with Mycobacterium tuberculosis

Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease

Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3

A strip-based assay for detection of CrfA enzyme activity to differentiate Mycobacterium tuberculosis and non-tuberculous mycobacteria

Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease

Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection

T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren

Gyanu Lamichhane Information

University

Position

Associate Professor Infectious Diseases

Citations(all)

5199

Citations(since 2020)

2315

Cited By

3962

hIndex(all)

38

hIndex(since 2020)

30

i10Index(all)

70

i10Index(since 2020)

59

Email

University Profile Page

Johns Hopkins University

Google Scholar

View Google Scholar Profile

Gyanu Lamichhane Skills & Research Interests

antibiotics

drug resistance

peptidoglycan

M. tuberculosis

non-tuberculous mycobacteria

Top articles of Gyanu Lamichhane

Title

Journal

Author(s)

Publication Date

Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations

Véronique Dartois

Tracey L Bonfield

Jim P Boyce

Charles L Daley

Thomas Dick

...

2024/3/19

Oxazolidinone for treatment of infections with Mycobacterium tuberculosis

2024/2/13

Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease

Tuberculosis

Binayak Rimal

Chandra M Panthi

Yi Xie

Daniel C Belz

Elisa H Ignatius

...

2024/2/9

Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3

Tuberculosis

Urs A Ochsner

Mary A De Groote

Thale C Jarvis

Hang Liu

Tessa Youmans

...

2023/1/1

A strip-based assay for detection of CrfA enzyme activity to differentiate Mycobacterium tuberculosis and non-tuberculous mycobacteria

Journal of Microbiological Methods

Rushna Wazahat

Pallavi Juneja

Varsha Chauhan

Rana Zaidi

Gyanu Lamichhane

...

2023/8/1

Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease

Msphere

Binayak Rimal

Danielle A Nicklas

Chandra M Panthi

Christopher K Lippincott

Daniel C Belz

...

2023/4/20

Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection

Antimicrobial agents and chemotherapy

Danielle A Nicklas

Emily C Maggioncalda

Elizabeth Story-Roller

Benjamin Eichelman

Chavis Tabor

...

2022/1/18

T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren

Antimicrobial agents and chemotherapy

Binayak Rimal

Hunter R Batchelder

Elizabeth Story-Roller

Chandra M Panthi

Chavis Tabor

...

2022/6/21

Glby, Encoded by MAB_3167c, Is Required for In Vivo Growth of Mycobacteroides abscessus and Exhibits Mild β-Lactamase Activity

Journal of bacteriology

Christos Galanis

Emily C Maggioncalda

Pankaj Kumar

Gyanu Lamichhane

2022/5/17

Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice

Tuberculosis

Divya Sriram

Rishi Wahi

Emily C Maggioncalda

Chandra M Panthi

Gyanu Lamichhane

2022/12/1

Early bactericidal activity of meropenem plus clavulanate (with or without rifampin) for tuberculosis: the COMRADE randomized, phase 2A clinical trial

American journal of respiratory and critical care medicine

Veronique De Jager

Nikhil Gupte

Silvia Nunes

Grace L Barnes

Rob Christiaan van Wijk

...

2022/5/15

Mechanistic insight on the inhibition of D, D-carboxypeptidase from Mycobacterium tuberculosis by β-lactam antibiotics: an ONIOM acylation study

Journal of Biomolecular Structure and Dynamics

Thandokuhle Ntombela

Anya Seupersad

Sibusiso Maseko

Collins U Ibeji

Gideon Tolufashe

...

2022/11/22

Allosteric cooperation in β-lactam binding to a non-classical transpeptidase

Elife

Nazia Ahmad

Sanmati Dugad

Varsha Chauhan

Shubbir Ahmed

Kunal Sharma

...

2022/4/27

Structure–Activity Relationship of Penem Antibiotic Side Chains Used against Mycobacteria Reveals Highly Active Compounds

ACS infectious diseases

Hunter R Batchelder

Trevor A Zandi

Amit Kaushik

Akul Naik

Elizabeth Story-Roller

...

2022/8/2

Penicillin binding proteins and β-lactamases of Mycobacterium tuberculosis: reexamination of the historical paradigm

MSphere

Gaurav Kumar

Christos Galanis

Hunter R Batchelder

Craig A Townsend

Gyanu Lamichhane

2022/2/23

Peptidoglycan compositional analysis of Mycobacterium smegmatis using high-resolution LC–MS

Scientific reports

Binayak Rimal

Sibusiso Senzani

Christopher Ealand

Gyanu Lamichhane

Bavesh Kana

...

2022/6/30

Glby, is a PBP with β-lactamase activity and is required for in vivo viability of M. abscessus

bioRxiv

Christos Galanis

Emily C Maggioncalda

Gaurav Kumar

Gyanu Lamichhane

2021/7/11

Assessment of carbapenems in a mouse model of Mycobacterium tuberculosis infection

PloS one

Ravindra Jadhav

Ricardo Gallardo-Macias

Gaurav Kumar

Samer S Daher

Amit Kaushik

...

2021/5/3

ß-Lactam combinations that exhibit synergy against Mycobacteroides abscessus clinical isolates.

Elizabeth Story-Roller

Christos Galanis

Gyanu Lamichhane

2021/4/6

β-Lactam combinations that exhibit synergy against Mycobacteroides abscessus clinical isolates

Antimicrobial agents and chemotherapy

Elizabeth Story-Roller

Christos Galanis

Gyanu Lamichhane

2021/3/18

See List of Professors in Gyanu Lamichhane University(Johns Hopkins University)